Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Northrop to Sell $1.65 Bln Unit to Private Equity
- By Megan Davies and Jui Chakravorty DasNEW YORK (Reuters) - Defense contractor Northrop Grumman NOC has agreed to sell its TASC consulting unit to two buyout firms, General Atlantic and Kohlberg Kravis Roberts & Co KKR, for $1.65 billion, the companies said on Sunday.The deal is the latest in a...
- News items 2009-11-08
- KIT Digital acquires TheFeedRoom for USD10m
- Online video distributor KIT Digital has acquired TheFeedRoom for approximately USD9.8m in stock, following its recent acquisition of Nunet. The deal price is less than many observers expected, given that TheFeedRoom has raised a reported USD61m since its launch in 1999. ...
- Articles 2009-10-05
Additional Resources
- Roche-Genentech: Lack of Deal Is All Goldman Sachs' Fault
- Roche's offer document for purchase of outstanding shares of Genentech is worth a look -- it gives a day-by-day, sometimes hour-by-hour explanation of what exactly happened between the two boards of directors since last summer, when Roche first proposed buying Genentech. It also explains why Roche is...
- Blog posts 2009-02-10
- InBev-Busch Deal Spooks Investors, but They're Wrong
- Ever since the financial crisis hit last month, people have been wondering about the InBev-Anheuser Busch merger. Will it go through? Yes, it almost certainly will. The main reason is that the $52 billion deal has solid financing behind it. And as the Dow Jones news service...
- Blog posts 2008-10-31
- Roche-Genentech Deal: $95 Bid Coming by February
- UPDATE: Roche CFO Erich Hunziker confirmed that the Genentech bid was "on track" and said this about jobs at Genentech: “the cuts we intend to do at Roche are much tougher†than any planned for Genentech, he said, according to Bloomberg. Roche won’t “kill the hens that laid the golden...
- Blog posts 2009-01-12
- Genentech's Levinson May Have No Change-of-Control Agreement in Roche Deal
- Genentech CEO Arthur Levinson gets no special benefits for agreeing to sell his company to Roche for $95 a share, according to the company's most recently filed proxy statement. That's a stark contrast to Schering-Plough CEO Fred Hassan, who had specific cash bonuses written into his compensation...
- Blog posts 2009-03-12
- Could Roche-Genentech Deal Price Actually Be Getting Lower?
- Is the acquisition price for Roche to buy Genentech actually getting cheaper? That is the tantalising notion raised in a column in the FT today. BNET readers will remember that the Roche-Genentech deal is conspicuous by its absence because Roche literally couldn't find enough money to borrow to take care...
- Blog posts 2008-12-18
- Anheuser Busch Discount to InBev Deal
- Scott Rothbort submits: Budweiser BUD continues to trade at a big discount to the $70 all cash acquisition price from InBev. On Thursday InBev (INBVF.PK) affirmed that the deal is on track. I hear from my investment banking experts that the deal is fully funded. However, the arbitrageurs who...
- External links 2008-11-09
- Aegis Q4: Not Talking to Havas; Deal Price Getting More Expensive; 780 Jobs Cut
- Aegis used its 2008 full year results to send a number of messages yesterday, some more confusing than others. Let's start with the financials: Aegis reported revenues for 2008 were up 21 percent to £1.3 billion; net income was down 4 percent to £89.2 billion (not adjusting...
- Blog posts 2009-03-20
- CLP A$600 million deal price talk.
- Oct 31, 2005 (The Australian Financial Markets Newsletter - INSTO - ABIX via COMTEX) -- Price talk has emerged on China Light & Power's impending $A600 million bond deal. The Hong Kong...
- Research articles 2005-10-31
- Some money managers pan AXA/MONY deal.(In The News)(AXA Financial Inc.)(The MONY Group Inc.)
- A day after AXA Financial Inc. agreed to pay $1.5 billion for The MONY Group Inc., some money managers said the price was too low. The deal price amounts to $31 per share, which would give shareholders a premium of 32% over the 1998 initial...
- Research articles 2003-09-22
- Unilab and Quest diagnostics lower deal price
- Quest Diagnostics and Unilab Corp. have announced that they will amend the terms of their merger agreement, cutting about $50 million from the purchase price. When the deal was announced in April, it was valued at about $900 million in cash and stock. But the total has fallen sharply as...
- Research articles 2002-12-09
- Yahoo Shareholder Pushes for Microsoft Search Deal
- Updated: Ivory Investment Management, a hedge fund that owns about 1.5 percent of Yahoo, is pushing the company to do a search deal with Microsoft, but the sticking point is valuation. Analysts say that Ivory’s assumptions sound optimistic. In a letter reported earlier by CNBC, Ivory urges...
- Blog posts 2008-12-10
- When to Walk Away from a Deal
- The Idea in Brief Is your company prone to "deal fever"--getting so excited while pursuing acquisitions that it skimps on due diligence? Caught up in the thrill of the chase, many firms use due diligence to justify...
- Articles 2007-12-13
- Roche Goes Hostile in Genentech Bid; Still Has No Financing Lined Up
- Roche, its pockets empty, has gone hostile in its bid for Genentech and offered holders a lower bid than its initial offer last summer. Roche is offering $86.50 a share, a 2.8% drop from the $89 it originally offered. Roche does not have financing lined up for...
- Blog posts 2009-01-30
- Shareholders Challenge Google Deal to Buy On2
- Google's agreeement to buy video compression software company On2 Technologies is being challenged in court by On2 shareholders unhappy about the $106.5 million price and the terms of the deal. The suit seeks class action status and a permanent injunction blocking the deal.SAN FRANCISCO, Aug 12 (Reuters)?Google Inc's deal to...
- News items 2009-08-12
- Dow Chemical may seek lower price for Rohm & Haas
- NEW YORK — The collapse of a joint venture with a state-owned Kuwaiti company may make Dow Chemical less willing to pay the $15.3-billion (U.S.) price tag for Rohm & Haas it initially agreed to last summer as energy prices peaked. Kuwait's government backed out of the deal with Dow...
- News items 2009-08-07
- The Pfizer-Shire Deal Worst-Case Scenario
- Earlier this week shares of Shire rose on rumors that Pfizer may be interested in acquiring the company, which is best-known for its ADHD drug Adderall XR. The notion that Pfizer is in acquisition mode has been driving people crazy for days. (See BNET's coverage of Pfizer Pfever here.) ...
- Blog posts 2009-01-07
- China forced to put a brave face on Fortescue iron ore deal
- China yesterday signalled a softer stance in its protracted iron ore negotiations with global miners, when it announced a face-saving deal with Australian miner Fortescue Metal. Fortescue has agreed to cut its iron ore prices by 35 per cent from last year's levels - less than the 45 per cent...
- News items 2009-08-17
- New Roche Offer and Genentech Squeeze-Out Ploy Put Focus on April's Avastin Results
- UPDATE: The Wall Street Journal reports that the boards of Genentech and Roche are "near an agreement" on a $95 a share bid. What are we to make of Roche's new $93 per share offer for Genentech? BNET previously suggested that market conditions were so rough that...
- Blog posts 2009-03-08
- << Previous
- page 1 of 1
- Next >>
